News and Trends 6 Oct 2016 NASH Maverick continues Rampage with €34M Cash Injection Genfit just added €34M to its cash pile through private placement to bankroll the development of its succeeding lead candidate, Elafibranor. Genfit has had a good year. Earlier this year, the company enrolled its first patient in Phase III clinical trails for Non-Alcoholic Stato-Hepatitis (NASH), and last month, it launched a new non-invasive diagnostic program. It’s […] October 6, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 29 Sep 2016 Interview: This Biotech Could Have the First HIV Cure on the Market InnaVirVax is one of the most advanced companies in the race to develop an HIV cure. At the SACHS Conference in Basel, we had the opportunity to pick the brain of the CEO, Joël Crouzet, about his company’s progress. Last week, we reviewed progress in biotech towards an HIV cure, which could hit the market […] September 29, 2016 - 1 minutemin - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2016 This French Founder is on a mission of Connecting Medical Devices What happens when you mix Internet of Things and Medical Devices? That’s what the French Startup, Instent, and its co-founder, Franz Bozsak, intend to find out. I had a chat with him after he won the EY prize of the Best Parisian Entrepreneur of the Year for his startup. My first question was which language should we speak? Bozsak is […] September 26, 2016 - 3 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2016 Genfit’s Non-Invasive Diagnostic could unlock the NASH Market Genfit reinforced its leading place in the race to find a cure for NASH when it announced this morning the launch of a program to validate their new diagnostic tool. Genfit is already leading in the development of a cure for Non-Alcoholic Stato-Hepatitis (NASH) with its candidate, Elafibranor, which is in Phase III trials. Now, the French €600M biopharma has […] September 20, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Sep 2016 How Tech Transfer brings Science from the Bench to the Bedside There are so many exciting discoveries in scientific research that could be used to cure, feed and fuel the world, but there is a giant gulf between science and business. Tech transfer aims to bridge the gap! I interviewed a number of experts in the field to tell you how. Since the first modern biotechnology […] September 19, 2016 - 6 minutesmins - By Marie Godar Share WhatsApp Twitter Linkedin Email
News and Trends 11 Feb 2016 Sanofi-Genzyme: Still successful 5 years after the acquisition? Back in 2011, France’s biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more than $20 billion, thus becoming the latest global drug giant to acquire a big biotech to foster its R&D pipeline. 5 years later, what’s the situation for Genzyme and Sanofi? So often when a large Pharma acquires a smaller Biotech, […] February 11, 2016 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email